Lates News

date
16/05/2025
Forte Biosciences (FBRX.US): The Q1 financial report for 2025 achieved revenue of 0 US dollars, the same as the previous value; earnings per share was -1.37 US dollars, compared to the previous value of -4.03 US dollars.
Latest
See all latestmore